113 related articles for article (PubMed ID: 6187721)
1. Semisynthesis of di-beta-lysylcapreomycin IIA, a capreomycin analog effective against viomycin-resistant Mycobacterium.
Wakamiya T; Shiba T
J Antibiot (Tokyo); 1983 Feb; 36(2):197-9. PubMed ID: 6187721
[No Abstract] [Full Text] [Related]
2. Activity of di-beta-lysyl-capreomycin IIA and palmitoyl tuberactinamine N against drug-resistant mutants with altered ribosomes.
Yamada T; Teshima T; Shiba T
Antimicrob Agents Chemother; 1981 Dec; 20(6):834-6. PubMed ID: 6173016
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial activity of palmitoyltuberactinamine N and di-beta-lysylcapreomycin IIA.
Yamada T; Yamanouchi T; Ono Y; Nagata A; Wakamiya T; Teshima T; Shiba T
J Antibiot (Tokyo); 1983 Dec; 36(12):1729-34. PubMed ID: 6198315
[TBL] [Abstract][Full Text] [Related]
4. Cross-resistance in M. tuberculosis to kanamycin, capreomycin and viomycin.
McClatchy JK; Kanes W; Davidson PT; Moulding TS
Tubercle; 1977 Mar; 58(1):29-34. PubMed ID: 68613
[TBL] [Abstract][Full Text] [Related]
5. Localization of co-resistance to streptomycin, kanamycin, capreomycin, and tuberactinomycin in core particles derived from ribosomes of viomycin-resistant Mycobacterium smegmatis.
Yamada T; Mizuguchi Y; Suga K
J Antibiot (Tokyo); 1976 Oct; 29(10):1124-6. PubMed ID: 62857
[No Abstract] [Full Text] [Related]
6. [The degree of cross-resistance to kanamycin (KM) of tubercle bacilli resistant to capreomycin (CPM), and the degree of cross-resistance to KM and CPM of tubercle bacilli resistant to viomycin (VM) (author's transl)].
Inagake H; Yamadori H; Inoue N; Mabuchi H; Ikeda N; Maekawa N
Kekkaku; 1980 Jul; 55(7):323-30. PubMed ID: 6162994
[No Abstract] [Full Text] [Related]
7. The antimycobacterial activity of capreomycin.
Lucchesi M
Antibiot Chemother; 1970; 16():27-31. PubMed ID: 4108891
[No Abstract] [Full Text] [Related]
8. [Evaluation of kanamycin, viomycin and capreomycin resistance of Mycobacterium tuberculosis].
Tomoda T; Minami Y; Maekawa Y; Oi Y
Rinsho Byori; 1971 Jun; 19(6):423-6. PubMed ID: 4111341
[No Abstract] [Full Text] [Related]
9. Molecular analysis of kanamycin and viomycin resistance in Mycobacterium smegmatis by use of the conjugation system.
Taniguchi H; Chang B; Abe C; Nikaido Y; Mizuguchi Y; Yoshida SI
J Bacteriol; 1997 Aug; 179(15):4795-801. PubMed ID: 9244267
[TBL] [Abstract][Full Text] [Related]
10. Cross-resistant relationships among the aminoglucoside antibiotics in Mycobacterium tuberculosis.
Tsukamura M; Mizuno S
J Gen Microbiol; 1975 Jun; 88(2):269-74. PubMed ID: 50402
[TBL] [Abstract][Full Text] [Related]
11. Resistance to the antibiotics viomycin and capreomycin in the Streptomyces species which produce them.
Skinner RH; Cundliffe E
J Gen Microbiol; 1980 Sep; 120(1):95-104. PubMed ID: 6163840
[TBL] [Abstract][Full Text] [Related]
12. [Drug resistance in Mycobacteria (author's transl)].
Yamada T; Masuda K
Kekkaku; 1976 Oct; 51(10):399-406. PubMed ID: 64637
[No Abstract] [Full Text] [Related]
13. Genetic and biochemical studies on drug-resistant mutants in Mycobacterium smegmatis.
Mizuguchi Y; Suga K; Masuda K; Yamada T
Jpn J Microbiol; 1974 Nov; 18(6):457-62. PubMed ID: 4141739
[No Abstract] [Full Text] [Related]
14. [Interactions of antitubercular drugs. II. Combined effects of rifampin, ethambutol, capreomycin, viomycin, ethionamide and cycloserine on mycobacterial growth in vitro].
Janowiec M; Zwolska-Kwiek Z
Pneumonol Pol; 1983 Dec; 51(12):607-12. PubMed ID: 6199778
[No Abstract] [Full Text] [Related]
15. Mapping of antibiotic resistance markers in Mycobacterium smegmatis.
Suga K; Mizuguchi Y
Jpn J Microbiol; 1974 Mar; 18(2):139-47. PubMed ID: 4139295
[No Abstract] [Full Text] [Related]
16. [Cross resistance of tubercle bacilli to KM, VM, CPM, LVM, and TUM. II. The susceptibility of antibiotic-resistant strains which were obtained in vitro to the five antibiotics (author's transl)].
Saito T; Fukuhara Y
Kekkaku; 1974 Apr; 49(4):91-6. PubMed ID: 4137393
[No Abstract] [Full Text] [Related]
17. Some experimental aspects of cross-resistance between capreomycin and viomycin.
Algeorge G; Petre A
Antibiot Chemother; 1970; 16():32-5. PubMed ID: 4108892
[No Abstract] [Full Text] [Related]
18. Molecular analysis of cross-resistance to capreomycin, kanamycin, amikacin, and viomycin in Mycobacterium tuberculosis.
Maus CE; Plikaytis BB; Shinnick TM
Antimicrob Agents Chemother; 2005 Aug; 49(8):3192-7. PubMed ID: 16048924
[TBL] [Abstract][Full Text] [Related]
19. In vitro microbiological characterization of novel cyclic homopentapeptides, CP-101,680 and CP-163,234, for animal health use.
Norcia LJ; Silvia AM; Dirlam JP; Schnur RC; Bergeron JM; Retsema JA; Hayashi SF
J Antibiot (Tokyo); 1999 Nov; 52(11):1007-16. PubMed ID: 10656573
[TBL] [Abstract][Full Text] [Related]
20. Study on tuberactinomycin-N. I. In vitro Antibacterial activity of TUM-N on Tubercle bacilli isolated from patients.
Shimizu T
Jpn J Antibiot; 1974 Aug; 27(4):463-70. PubMed ID: 4140247
[No Abstract] [Full Text] [Related]
[Next] [New Search]
